Gilles C, Polette M, Seiki M, Birembaut P, Thompson E W
Department of Cell Biology, Georgetown University Medical Center, Washington D.C. 20007, USA.
Lab Invest. 1997 May;76(5):651-60.
We have previously demonstrated that fibroblasts and invasive human breast carcinoma (HBC) cells specifically activate matrix metalloproteinase-2 (MMP-2) when cultured on 3-dimensional gels of type I collagen but not a range of other substrates. We show here the constitutive expression of membrane-type 1 (MT1)-MMP in both fibroblasts, and invasive HBC cell lines, that have fibroblastic attributes presumably acquired through an epithelial-to-mesenchymal transition (EMT). Treatment with collagen type I increased the steady-state MT1-MMP mRNA levels in these cells but did not induce either MT1-MMP expression or MMP-2 activation in noninvasive breast carcinoma cell lines, which retain epithelial features. Basal MT3-MMP mRNA expression had a pattern similar to that of MT1-MMP but was not up-regulated by collagen. MT4-MMP mRNA was seen in both invasive and noninvasive HBC cell lines and was also not collagen-regulated, and MT2-MMP mRNA was not detected in any of the HBC cell lines tested. These data support a role for MT1-MMP in the collagen-induced MMP-2-activation seen in these cells. In situ hybridization analysis of archival breast cancer specimens revealed a close parallel in expression of both collagen type I and MT1-MMP mRNA in peritumoral fibroblasts, which was correlated with aggressiveness of the lesion. Relatively high levels of expression of both mRNA species were seen in fibroblasts close to invasive tumor nests and, although only focally, in certain areas close to preinvasive tumors. These foci may represent hot spots for local degradation and invasive progression. Collectively, these results implicate MT1-MMP in collagen-stimulated MMP-2 activation and suggest that this mechanism may be employed in vivo by both tumor-associated fibroblasts and EMT-derived carcinoma cells to facilitate increased invasion and/or metastasis.
我们之前已经证明,成纤维细胞和侵袭性人乳腺癌(HBC)细胞在I型胶原蛋白的三维凝胶上培养时会特异性激活基质金属蛋白酶-2(MMP-2),而在一系列其他底物上培养时则不会。我们在此展示了膜型1(MT1)-MMP在成纤维细胞和具有成纤维细胞特性(可能是通过上皮-间质转化(EMT)获得)的侵袭性HBC细胞系中的组成性表达。用I型胶原蛋白处理可增加这些细胞中MT1-MMP的稳态mRNA水平,但不会诱导保留上皮特征的非侵袭性乳腺癌细胞系中的MT1-MMP表达或MMP-2激活。基础MT3-MMP mRNA表达模式与MT1-MMP相似,但不受胶原蛋白上调。MT4-MMP mRNA在侵袭性和非侵袭性HBC细胞系中均可见,也不受胶原蛋白调节,并且在任何测试的HBC细胞系中均未检测到MT2-MMP mRNA。这些数据支持MT1-MMP在这些细胞中胶原蛋白诱导的MMP-2激活中发挥作用。对存档乳腺癌标本的原位杂交分析显示,肿瘤周围成纤维细胞中I型胶原蛋白和MT1-MMP mRNA的表达密切平行,这与病变的侵袭性相关。在靠近侵袭性肿瘤巢的成纤维细胞中可见两种mRNA的相对高水平表达,并且在靠近侵袭前肿瘤的某些区域虽然只是局部可见。这些病灶可能代表局部降解和侵袭进展的热点。总体而言,这些结果表明MT1-MMP参与胶原蛋白刺激的MMP-2激活,并表明这种机制可能在体内被肿瘤相关成纤维细胞和EMT衍生的癌细胞共同采用,以促进侵袭和/或转移增加。